Alampi MM, Kozlíková M, Mariangeli M, Civita S, Delcanale P, Mussini A, Diaspro A, Bianchini P, Weyergang A, Skarpen E, Berg K, Viappiani C, Abbruzzetti S, Selbo PK(2025) Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab Biomed Pharmacother, 191, 118550(in press) DOI 10.1016/j.biopha.2025.118550, PubMed 40946581
Switlyk MD, Dale E, Tafjord S, Willumsen L, Hole KH, Hompland T(2025) Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer Sci Rep, 15(1), 31889 DOI 10.1038/s41598-025-17284-8, PubMed 40883428
Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
